Caricamento...
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Chemotherapy is the primary established systemic treatment for patients with triple-negative breast cancer (TNBC) in both the early and advanced-stages of the disease. The lack of targeted therapies and the poor prognosis of patients with TNBC have fostered a major effort to discover actionable mole...
Salvato in:
| Pubblicato in: | Nat Rev Clin Oncol |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5461122/ https://ncbi.nlm.nih.gov/pubmed/27184417 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2016.66 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|